BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
390.82
Molecular Formula
C21H15ClN4O2
Notes
Research use only, not for human use.
Receptor
RSV
CAS Number
1646857-24-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1434225-01 0.02 mg (E-Coli)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details 
MBS1434225-02 0.02 mg (Yeast)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details MBS1434225-03 0.1 mg (E-Coli)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details 
MBS1434225-04 0.1 mg (Yeast)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details MBS1434225-05 0.02 mg (Baculovirus)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details 
MBS1434225-06 0.02 mg (Mammalian-Cell)
Recombinant Vibrio parahaemolyticus NADH pyrophosphatase (nudC)
Ask
View Details